EPRONTIA

Serial Number 90690878
Registration 6902565
700

Registration Progress

Application Filed
May 5, 2021
Under Examination
Apr 12, 2022
Approved for Publication
Feb 15, 2022
Published for Opposition
Feb 15, 2022
Registered
Nov 15, 2022

Trademark Image

EPRONTIA

Basic Information

Serial Number
90690878
Registration Number
6902565
Filing Date
May 5, 2021
Registration Date
November 15, 2022
Published for Opposition
February 15, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 15, 2022
Registration
Registered
Classes
005

Rights Holder

Azurity Pharmaceuticals, Inc.

03
Address
8 Cabot Road, Suite 2000
Woburn, MA 01801

Ownership History

Azurity Pharmaceuticals, Inc.

Original Applicant
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Owner at Publication
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Original Registrant
03
Woburn, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

Next Deadline
1057 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20221115)
Due Date
November 15, 2028
Grace Period Ends
May 15, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

16 events
Date Code Type Description Documents
Mar 19, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Nov 15, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 15, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 11, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 9, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 9, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 25, 2022 IUAF S USE AMENDMENT FILED Loading...
Sep 9, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 25, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 12, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 15, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 15, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 26, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 10, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 7, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 6, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical formulations and compositions containing topiramate; pharmaceutical preparations for the preventative treatment of seizures or migraines; anticonvulsants
First Use Anywhere: Dec 6, 2021
First Use in Commerce: Dec 6, 2021

Classification

International Classes
005